fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

Along with the increasing number of cases, there are growing concerns over the effect COVID-19 has on primary healthcare Over the past few weeks, reports are being published on the poor primary healthcare people are receiving in this current pandemic. This show about COVID affecting people in more ways than one, directly or indirectly. Cases of mental health being affected ...

Three of the studies observed by ICMR suggest that Hydroxychloroquine reduces the chances of getting infected with the virus and hence should be used as a preventive drug against the novel coronavirus. The conclusion is being drawn on the basis of 3 studies conducted by the ICMR (The Indian Council of Medical Research) and suggested that the drug should be ...

Over 20 research institutes in India including the Indian Council of Medical Research (ICMR), and The National Institute of Virology (NIV), Pune are working to develop a vaccine for the SARS-nCOV-2. The Indian government has received 7000 tech-based proposals from private companies and individuals from all over the country to fight COVID-19. The government is dealing with scaling up the ...

As the COVID-19 pandemic continues to increase the death tolls, a need for a treatment is greater than ever. Serum institute CEO Adar Poonawala says they will proceed with human trials for a possible COVID-19 vaccine by year-end.  As the whole world is battling against the pandemic COVID-19, the medical industries have been working 24/7 on finding a vaccine to ...

The rising number of COVID-19 cases across the globe has prompted many pharma giants to step ahead for potential vaccine development. Countries like UK alone has witnessed more than 5000 deaths and several cases and is amongst the worst-hit country in the world. To overcome the menace of COVID-19, the UK pharma start-up Imophoron has cast off several vaccine candidates ...

In the global race to find a potential vaccine against COVID-19, Australia has joined with its two potential vaccine candidates being tested in the lab for efficacy. The research is being carried out at the Commonwealth Scientific and Industrial Research Organisation (CSIRO). The scientists are not only looking at the efficacy of the potential vaccine candidates but also for the ...

The therapeutic efficacy of any drug depends on how effectively it can be delivered to the target site. This is where drug delivery mechanisms and carriers play a critical role to ensure proficient pharmacodynamics and pharmacokinetics. The availability of the drug at the target site, at the right time and right concentration helps to enhance its therapeutic performance and reduce ...

Convalescent plasma therapy aims at using antibodies from the blood of recovered COVID-19 cases, to treat those who are currently severely infected from the novel virus.   With a lot of stakes on drugs, but no results, the medical industry is turning to new technologies in need to desperately slow the current pandemic COVID-19. Recently, as a first, a 49-year-old COVID-19 ...

Cadila Pharmaceuticals is taking the lead in the race of fight against COVID-19 through its research breakthrough of immunomodulator. The company has recently tested the immunomodulator successfully in four COVID positive patients.   The development of the immunomodulator by Cadila was carried out in partnership with our country’s premier research organization – Council of Scientific and Industrial Research (CSIR). Phase -3 ...